Found: 187
Select item for more details and to access through your institution.
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?
- Published in:
- Acta Diabetologica, 2015, v. 52, n. 3, p. 433, doi. 10.1007/s00592-014-0635-6
- By:
- Publication type:
- Article
Clinical Pharmacology of Oral Octreotide Capsules for the Treatment of Acromegaly.
- Published in:
- touchREVIEWS in Endocrinology, 2024, v. 20, n. 1, p. 37, doi. 10.17925/EE.2024.20.1.9
- By:
- Publication type:
- Article
Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1026416
- By:
- Publication type:
- Article
Longitudinal Changes in Physical Function and Their Impact on Health Outcomes in COVID-19 Patients.
- Published in:
- Nutrients, 2023, v. 15, n. 20, p. 4474, doi. 10.3390/nu15204474
- By:
- Publication type:
- Article
The Potential Impact of Inducing a Restriction in Reimbursement Criteria on Vitamin D Supplementation in Osteoporotic Patients with or without Fractures.
- Published in:
- Nutrients, 2022, v. 14, n. 9, p. 1877, doi. 10.3390/nu14091877
- By:
- Publication type:
- Article
Vitamin D in Osteosarcopenic Obesity.
- Published in:
- Nutrients, 2022, v. 14, n. 9, p. 1816, doi. 10.3390/nu14091816
- By:
- Publication type:
- Article
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Picotamide, a dual TXB synthetase inhibitor and TXB receptor antagonist, reduces exercise-induced albuminuria in microalbuminuric patients with NIDDM.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE).
- Published in:
- Pituitary, 2024, v. 27, n. 4, p. 381, doi. 10.1007/s11102-024-01397-w
- By:
- Publication type:
- Article
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma.
- Published in:
- Pituitary, 2024, v. 27, n. 4, p. 370, doi. 10.1007/s11102-024-01394-z
- By:
- Publication type:
- Article
Pituitary: hic manebimus optime.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Correction: consensus on criteria for acromegaly diagnosis and remission.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Consensus on criteria for acromegaly diagnosis and remission.
- Published in:
- Pituitary, 2024, v. 27, n. 1, p. 7, doi. 10.1007/s11102-023-01360-1
- By:
- Publication type:
- Article
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 831, doi. 10.1007/s11102-022-01266-4
- By:
- Publication type:
- Article
Pituitary tumor centers of excellence for Cushing's disease.
- Published in:
- Pituitary, 2022, v. 25, n. 5, p. 772, doi. 10.1007/s11102-022-01264-6
- By:
- Publication type:
- Article
Novel approaches to bone comorbidity in Cushing's disease: an update.
- Published in:
- Pituitary, 2022, v. 25, n. 5, p. 754, doi. 10.1007/s11102-022-01252-w
- By:
- Publication type:
- Article
COVID-19 and the pituitary.
- Published in:
- Pituitary, 2021, v. 24, n. 3, p. 465, doi. 10.1007/s11102-021-01148-1
- By:
- Publication type:
- Article
A Pituitary Society update to acromegaly management guidelines.
- Published in:
- Pituitary, 2021, v. 24, n. 1, p. 1, doi. 10.1007/s11102-020-01091-7
- By:
- Publication type:
- Article
The tale in evolution: clarity, consistency and consultation, not contradiction and confusion.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Hyperprolactinemia and bone.
- Published in:
- Pituitary, 2020, v. 23, n. 3, p. 314, doi. 10.1007/s11102-020-01041-3
- By:
- Publication type:
- Article
Effects of octreotide on autophagy markers and cell viability markers related to metabolic activity in rat pituitary tumor cells.
- Published in:
- Pituitary, 2020, v. 23, n. 3, p. 223, doi. 10.1007/s11102-020-01028-0
- By:
- Publication type:
- Article
Diagnosis and management of prolactinomas: current challenges.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement.
- Published in:
- Pituitary, 2019, v. 22, n. 6, p. 569, doi. 10.1007/s11102-019-00988-2
- By:
- Publication type:
- Article
Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study.
- Published in:
- Pituitary, 2019, v. 22, n. 5, p. 476, doi. 10.1007/s11102-019-00977-5
- By:
- Publication type:
- Article
Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.
- Published in:
- Pituitary, 2018, v. 21, n. 6, p. 663, doi. 10.1007/s11102-018-0912-4
- By:
- Publication type:
- Article
Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.
- Published in:
- Pituitary, 2018, v. 21, n. 3, p. 309, doi. 10.1007/s11102-018-0878-2
- By:
- Publication type:
- Article
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.
- Published in:
- Pituitary, 2018, v. 21, n. 3, p. 302, doi. 10.1007/s11102-018-0873-7
- By:
- Publication type:
- Article
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.
- Published in:
- Pituitary, 2017, v. 20, n. 5, p. 489, doi. 10.1007/s11102-017-0838-2
- By:
- Publication type:
- Article
SAGIT: clinician-reported outcome instrument for managing acromegaly in clinical practice-development and results from a pilot study.
- Published in:
- Pituitary, 2016, v. 19, n. 1, p. 39, doi. 10.1007/s11102-015-0681-2
- By:
- Publication type:
- Article
New oral anticoagulants and pituitary apoplexy.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro.
- Published in:
- Pituitary, 2014, v. 17, n. 3, p. 203, doi. 10.1007/s11102-013-0488-y
- By:
- Publication type:
- Article
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas.
- Published in:
- Pituitary, 2011, v. 14, n. 4, p. 299, doi. 10.1007/s11102-011-0293-4
- By:
- Publication type:
- Article
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cells.
- Published in:
- Pituitary, 2011, v. 14, n. 3, p. 242, doi. 10.1007/s11102-010-0288-6
- By:
- Publication type:
- Article
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review.
- Published in:
- Pituitary, 2010, v. 13, n. 1, p. 60, doi. 10.1007/s11102-009-0169-z
- By:
- Publication type:
- Article
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly.
- Published in:
- Pituitary, 2009, v. 12, n. 3, p. 196, doi. 10.1007/s11102-008-0157-8
- By:
- Publication type:
- Article
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency.
- Published in:
- Pituitary, 2008, v. 11, n. 1, p. 55, doi. 10.1007/s11102-007-0069-z
- By:
- Publication type:
- Article
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
- Published in:
- Pituitary, 2006, v. 9, n. 3, p. 221, doi. 10.1007/s11102-006-0267-0
- By:
- Publication type:
- Article
Cushing's Syndrome and Bone.
- Published in:
- Pituitary, 2004, v. 7, n. 4, p. 249, doi. 10.1007/s11102-005-1051-2
- By:
- Publication type:
- Article
The Effects of a Continuous Infusion of Hexarelin on Pulsatile Growth Hormone Release, Growth Axis and Galanin Gene Expression and on the Response of the Growth Axis to Growth Hormone-Releasing Hormone.
- Published in:
- Pituitary, 2000, v. 2, n. 4, p. 253, doi. 10.1023/A:1009957015563
- By:
- Publication type:
- Article
Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients.
- Published in:
- Internal & Emergency Medicine, 2012, v. 7, n. 3, p. 257, doi. 10.1007/s11739-011-0527-5
- By:
- Publication type:
- Article
Vitamin D status in Armenian women: a stratified cross-sectional cluster analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mechanism of Action of Hexarelin and GHRP-6: Analysis of the Involvement of GHRH and Somatostatin in the Rat.
- Published in:
- Neuroendocrinology, 1995, v. 61, n. 1, p. 44, doi. 10.1159/000126826
- By:
- Publication type:
- Article
Effect of Galanin and Arginine, Alone or in Combination, on Growth Hormone Secretion in Adult Patients Treated with Glucocorticoids.
- Published in:
- Neuroendocrinology, 1993, v. 57, n. 5, p. 843, doi. 10.1159/000126443
- By:
- Publication type:
- Article
Hypothalamic Regulation of Impaired Growth Hormone Secretion in Diabetic Rats.
- Published in:
- Neuroendocrinology, 1992, v. 55, n. 5, p. 500, doi. 10.1159/000126163
- By:
- Publication type:
- Article
Hypothalamic Regulation of Impaired Growth Hormone Secretion in Diabetic Rats.
- Published in:
- Neuroendocrinology, 1992, v. 55, n. 5, p. 506, doi. 10.1159/000126164
- By:
- Publication type:
- Article
Durable biochemical response and safety with oral octreotide capsules in acromegaly.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 6, p. 733, doi. 10.1530/EJE-22-0220
- By:
- Publication type:
- Article
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response.
- Published in:
- European Journal of Endocrinology, 2021, v. 184, n. 2, p. 217, doi. 10.1530/EJE-20-0767
- By:
- Publication type:
- Article